Tricot G - Search Results

1

RARα2 expression confers myeloma stem cell features.

Yang Y, Shi J, Tolomelli G, Xu H, Xia J, Wang H, Zhou W, Zhou Y, Das S, Gu Z, Levasseur D, Zhan F, Tricot G. Yang Y, et al. Among authors: tricot g. Blood. 2013 Aug 22;122(8):1437-47. doi: 10.1182/blood-2013-02-482919. Epub 2013 Jul 11. Blood. 2013. PMID: 23847194 Free PMC article.

2

NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.

Zhou W, Yang Y, Xia J, Wang H, Salama ME, Xiong W, Xu H, Shetty S, Chen T, Zeng Z, Shi L, Zangari M, Miles R, Bearss D, Tricot G, Zhan F. Zhou W, et al. Among authors: tricot g. Cancer Cell. 2013 Jan 14;23(1):48-62. doi: 10.1016/j.ccr.2012.12.001. Cancer Cell. 2013. PMID: 23328480 Free PMC article.

3

Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma.

Yang Y, Shi J, Gu Z, Salama ME, Das S, Wendlandt E, Xu H, Huang J, Tao Y, Hao M, Franqui R, Levasseur D, Janz S, Tricot G, Zhan F. Yang Y, et al. Among authors: tricot g. Cancer Res. 2015 Feb 1;75(3):594-604. doi: 10.1158/0008-5472.CAN-14-2362. Epub 2015 Jan 14. Cancer Res. 2015. PMID: 25589346 Free PMC article.

4

Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation.

Gu Z, Wang H, Xia J, Yang Y, Jin Z, Xu H, Shi J, De Domenico I, Tricot G, Zhan F. Gu Z, et al. Among authors: tricot g. Cancer Res. 2015 Jun 1;75(11):2211-21. doi: 10.1158/0008-5472.CAN-14-3804. Epub 2015 Apr 8. Cancer Res. 2015. PMID: 25855377 Free PMC article.

5

NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma.

Huang J, Zhou Y, Thomas GS, Gu Z, Yang Y, Xu H, Tricot G, Zhan F. Huang J, et al. Among authors: tricot g. Clin Cancer Res. 2015 Dec 15;21(24):5532-42. doi: 10.1158/1078-0432.CCR-15-0254. Epub 2015 Jul 8. Clin Cancer Res. 2015. PMID: 26156395 Free PMC article.

6

RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma.

Wang S, Tricot G, Shi L, Xiong W, Zeng Z, Xu H, Zangari M, Barlogie B, Shaughnessy JD Jr, Zhan F. Wang S, et al. Among authors: tricot g. Blood. 2009 Jul 16;114(3):600-7. doi: 10.1182/blood-2008-12-194126. Epub 2009 May 20. Blood. 2009. PMID: 19458357 Free PMC article.

7

Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance.

Shi L, Wang S, Zangari M, Xu H, Cao TM, Xu C, Wu Y, Xiao F, Liu Y, Yang Y, Salama M, Li G, Tricot G, Zhan F. Shi L, et al. Among authors: tricot g. Oncotarget. 2010 May;1(1):22-33. doi: 10.18632/oncotarget.105. Oncotarget. 2010. PMID: 20930946 Free PMC article.

8

Progress in myeloma stem cells.

Cruz RD, Tricot G, Zangari M, Zhan F. Cruz RD, et al. Among authors: tricot g. Am J Blood Res. 2011;1(2):135-45. Epub 2011 Sep 8. Am J Blood Res. 2011. PMID: 22432075 Free PMC article.

9

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma.

Yang Y, Zhou W, Xia J, Gu Z, Wendlandt E, Zhan X, Janz S, Tricot G, Zhan F. Yang Y, et al. Among authors: tricot g. Oncotarget. 2014 Dec 15;5(23):11986-97. doi: 10.18632/oncotarget.2388. Oncotarget. 2014. PMID: 25230277 Free PMC article.

10

Nek2 is a novel regulator of B cell development and immunological response.

Gu Z, Zhou W, Huang J, Yang Y, Wendlandt E, Xu H, He X, Tricot G, Zhan F. Gu Z, et al. Among authors: tricot g. Biomed Res Int. 2014;2014:621082. doi: 10.1155/2014/621082. Epub 2014 Nov 17. Biomed Res Int. 2014. PMID: 25485281 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

489 results

Search Page

Filters